X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3011) 3011
Publication (293) 293
Newsletter (141) 141
Book Review (25) 25
Book Chapter (20) 20
Book / eBook (8) 8
Magazine Article (6) 6
Dissertation (5) 5
Newspaper Article (5) 5
Conference Proceeding (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2404) 2404
female (2203) 2203
leiomyoma (1223) 1223
index medicus (1207) 1207
adult (1111) 1111
middle aged (959) 959
leiomyoma - genetics (939) 939
leiomyoma - pathology (822) 822
uterine neoplasms - genetics (778) 778
obstetrics & gynecology (707) 707
uterine neoplasms - pathology (630) 630
fibroids (544) 544
tumors (515) 515
oncology (472) 472
male (443) 443
leiomyoma - metabolism (439) 439
pathology (395) 395
uterus (390) 390
hysterectomy (364) 364
aged (356) 356
uterine neoplasms - metabolism (356) 356
reproductive biology (355) 355
uterine leiomyoma (353) 353
cancer (345) 345
immunohistochemistry (333) 333
leiomyoma - surgery (332) 332
expression (306) 306
uterine leiomyomas (294) 294
research (291) 291
women (286) 286
genetic aspects (284) 284
animals (262) 262
leiomyomas (259) 259
mutation (259) 259
genetics & heredity (257) 257
analysis (252) 252
surgery (251) 251
uterine neoplasms - surgery (242) 242
diagnosis (236) 236
medicine & public health (235) 235
myometrium (232) 232
gene expression (222) 222
risk factors (221) 221
health aspects (215) 215
pregnancy (215) 215
uterine fibroids (214) 214
leiomyosarcoma (209) 209
gene (206) 206
gynecology (195) 195
myometrium - metabolism (195) 195
obstetrics and gynecology (195) 195
leiomyoma - diagnosis (184) 184
estrogen (166) 166
care and treatment (164) 164
diagnosis, differential (164) 164
endocrinology & metabolism (155) 155
genetic predisposition to disease (154) 154
human genetics (151) 151
genes (150) 150
internal medicine (150) 150
prognosis (150) 150
smooth muscle (150) 150
smooth-muscle tumors (146) 146
cell biology (145) 145
retrospective studies (144) 144
gene expression regulation, neoplastic (143) 143
tumor cells, cultured (142) 142
genetic research (140) 140
article (139) 139
karyotyping (135) 135
endometriosis (134) 134
gene-expression (134) 134
aged, 80 and over (133) 133
polymerase chain reaction (133) 133
adolescent (132) 132
endocrinology (132) 132
leiomyoma - complications (131) 131
female genital diseases and pregnancy complications (128) 128
reverse transcriptase polymerase chain reaction (128) 128
leiomyosarcoma - pathology (127) 127
uterine neoplasms - diagnosis (127) 127
neoplasms (125) 125
progesterone (125) 125
growth (124) 124
leiomyoma - drug therapy (123) 123
apoptosis (122) 122
case-control studies (121) 121
leiomyoma - therapy (120) 120
treatment outcome (119) 119
cells (117) 117
medicine (115) 115
base sequence (114) 114
pathogenesis (112) 112
uterine neoplasms - therapy (112) 112
leiomyosarcoma - genetics (110) 110
rna, messenger - metabolism (110) 110
mutations (109) 109
chromosome aberrations (105) 105
young adult (105) 105
management (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3052) 3052
French (29) 29
Russian (23) 23
German (18) 18
Chinese (17) 17
Spanish (15) 15
Japanese (11) 11
Polish (10) 10
Italian (7) 7
Hungarian (6) 6
Korean (3) 3
Czech (2) 2
Bulgarian (1) 1
Danish (1) 1
Dutch (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, p. e40015
The relationship between benign uterine leiomyomas and their malignant counterparts, i.e. leiomyosarcomas and smooth muscle tumors of uncertain malignant... 
NEOPLASMS | LEIOMYOSARCOMA | LEIOMYOMA | MEDIATOR | MULTIDISCIPLINARY SCIENCES | X-CHROMOSOME INACTIVATION | BROAD LIGAMENT | COMPARATIVE GENOMIC HYBRIDIZATION | ABERRATIONS | BETA-CATENIN EXPRESSION | CLONAL ORIGINS | Mediator Complex - metabolism | Uterine Neoplasms - pathology | Humans | DNA, Complementary - genetics | Gene Expression Regulation, Neoplastic | Molecular Sequence Data | Leiomyoma - pathology | Smooth Muscle Tumor - genetics | Cell Transformation, Neoplastic - genetics | DNA Mutational Analysis | Base Sequence | Female | Soft Tissue Neoplasms - genetics | Uterine Neoplasms - genetics | Mediator Complex - genetics | Smooth Muscle Tumor - pathology | Mutation - genetics | beta Catenin - metabolism | Genome, Human - genetics | Protein Transport | Wnt Signaling Pathway - genetics | Alleles | Soft Tissue Neoplasms - pathology | Cell Transformation, Neoplastic - pathology | Leiomyoma - genetics | Immunohistochemistry | Development and progression | Gene mutations | Cancer | Wnt protein | Mesenchyme | Smooth muscle | Subgroups | β-catenin | Alterations | Uterus | Genetics | Tumorigenesis | Localization | Deoxyribonucleic acid--DNA | Sequences | Hot spots | Benign | Muscles | Fibroids | Breast cancer | RNA polymerase | Gene expression | Pathology | MicroRNAs | Pancreatic cancer | Mutation | Tumors | Deoxyribonucleic acid | DNA
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 05/2013, Volume 370, Issue 1-2, pp. 138 - 148
Journal Article
Journal Article
Oncogene, ISSN 0950-9232, 2018, Volume 38, Issue 15, pp. 2722 - 2735
Progesterone and its receptor, PR, are essential for uterine leiomyoma (LM, a.k.a., fibroid) tumorigenesis, but the underlying cellular and molecular... 
GENE | ONCOLOGY | PATHWAY | MEDIATOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | LIGAND | MUTATIONS | OSTEOCLAST DIFFERENTIATION | TRANSCRIPTIONAL REGULATION | CANCER | CELL BIOLOGY | Transcriptional Activation - genetics | Gene Expression - drug effects | Gene Expression - genetics | Humans | Middle Aged | Transcription Initiation Site - drug effects | Transcriptional Activation - drug effects | Receptors, Progesterone - genetics | Adult | Female | Gene Expression Regulation, Neoplastic - drug effects | Gene Expression Regulation, Neoplastic - genetics | Uterine Neoplasms - genetics | Cell Proliferation - genetics | Mediator Complex - genetics | DNA Methylation - genetics | RANK Ligand - genetics | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Stem Cells - pathology | Promegestone - pharmacology | Cell Proliferation - drug effects | Progesterone - genetics | DNA Methylation - drug effects | Leiomyoma - genetics | Cell proliferation | Leiomyoma | Women | Care and treatment | Usage | Research | Hysterectomy | Receptors | Analysis | Stem cells | Genetic aspects | Progesterone | Health aspects | NF-κB protein | Myometrium | Transcription | Gene expression | Cyclin D1 | Cell growth | Molecular modelling | Uterus | DNA methylation | Tumorigenesis | Mutation | TRANCE protein | Binding sites | Histone post-translational modifications | Hormone receptors | Cytokines
Journal Article